PROSPERiA, a artificial intelligence -based startup, has closed a seed round totaling $2 million to expand the reach of its diagnostic solutions to the rest of Mexico. PROSPERiA, first launched in 2021 to provide chronic disease testing solutions to emerging countries, has been used to assess the health of 10,000 patients and can detect more than 4,500 potential diseases.
PROSPERiA's diagnostic process
Cristina Campero said: "With this investment we hope to boost our growth in recent months and achieve our goal in 2022 of having a 10,000 patients a month, not just in Mexico City, PROSPERiA’s CEO said in an interview that the investment came from Sweden’s Cardo Health fund. PROSPERIA and the Fund will work together to use this technology to improve the health and quality of life of people in emerging market countries.
She added that Cardo Health’s experience and the markets PROSPERiA is tapping will enable the company to create new solutions. The company is already building a comprehensive health management platform through which it can provide patients with better care opportunities in a timely manner.
Campero said PROSPERiA went through a long and complicated process before finding Cardo Health because of the unique difficulties of running a technology startup in Latin America. Although Latin America has seen an investment boom in recent years, 74% of this investment is concentrated in four areas: fintech, real estate technology, logistics and e-commerce. Healthcare investments account for less than 7% of all investments Latin America has received in recent years, lagging slightly behind the sector.
Ms. Campero, CEO of PROSPERiA
She said that the complexity faced by medtech companies in Latin America in the financing process is mainly due to several factors. For example, their business models are often more complex and riskier; they are often Transactional B2B models have few international success stories. In addition, regulation of such companies remains ambiguous in Mexico and Latin America, creating uncertainty and increasing business risks.
Mexico’s health culture also exacerbates these. Difficulties. Although this culture began to shift during the epidemic, Campero explained that the region still lacks a preventive health culture “This means that people are less motivated to use early screening technology.
Considering that less than 14% of funding in Latin America in 2020 went to startups founded or co-founded by women, this news is also a reason to celebrate women in leadership roles. “This is obviously a reason for us,” Campero said. It's a very exciting period, especially for me because as the CEO of the company, I'm in a very privileged position. I feel extremely privileged to have the opportunity to serve as a role model for other women considering joining the entrepreneurial ecosystem. My journey has not been simple, but it has proven to be possible. We need to work harder to increase women’s participation in the workplace. "
